- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
Patent holdings for IPC class A61K 31/137
Total number of patents in this class: 4752
10-year publication summary
|
376
|
371
|
401
|
405
|
429
|
412
|
373
|
350
|
293
|
46
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Antecip Bioventures II LLC | 349 |
199 |
| Novartis AG | 10481 |
54 |
| The Regents of the University of California | 20366 |
51 |
| Grünenthal GmbH | 544 |
42 |
| Zogenix International Limited | 76 |
42 |
| Axsome Therapeutics, Inc. | 310 |
39 |
| Nalpropion Pharmaceuticals LLC | 69 |
39 |
| The Procter & Gamble Company | 21977 |
38 |
| Nevakar Injectables Inc. | 45 |
31 |
| Aquestive Therapeutics, Inc. | 185 |
28 |
| Noven Pharmaceuticals, Inc. | 89 |
27 |
| Radius Pharmaceuticals, Inc. | 56 |
26 |
| The Trustees of Columbia University in the City of New York | 3614 |
23 |
| Gruenenthal GmbH | 100 |
23 |
| Pharnext | 85 |
22 |
| Duke University | 3157 |
21 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3084 |
21 |
| Ironshore Pharmaceuticals & Development, Inc. | 37 |
20 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2943 |
20 |
| Clexio Biosciences Ltd. | 101 |
19 |
| Other owners | 3967 |